nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.06.2008 | Original Paper

Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound

verfasst von: C. F. Dietrich, B. Braden, M. Hocke, M. Ott, A. Ignee

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Contrast enhanced ultrasound (CEUS) is a new imaging method for detection and characterisation of liver tumours. The role of CEUS in pancreatic disease is less obvious. We prospectively evaluated CEUS for characterization of undetermined solid pancreatic lesions (gold standard histology).

Patients and methods

A total of 112 solitary undetermined pancreatic masses (70 ductal adenocarcinoma and 42 neoplastic nodules of other origin) were prospectively examined in patients without metastatic disease using transabdominal ultrasound. Tumour enhancing features were analyzed in comparison to the surrounding pancreatic parenchyma in patients with adequate visualisation.

Results

The sign of iso-hypervascularity as a sign of non-ductal adenocarcinoma showed a sensitivity of 100%, specifity of 90% and accuracy of 93.8%. The sign of hypovascularity as a sign of ductal adenocarcinoma showed a sensitivity of 90%, specifity of 100% and an accuracy of 93.8%.

Conclusion

CEUS allows differential diagnosis of ductal adenocarcinoma and non-ductal adenocarcinoma (mainly neuroendocrine tumours and (microcystic) serous pancreatic adenoma) in the most of cases.

Adsay NV, Basturk O, Klimstra DS, Kloppel G (2004) Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol 21(4):260–267PubMedCrossRef

D’Onofrio M, Caffarri S, Zamboni G, Falconi M, Mansueto G (2004) Contrast-enhanced ultrasonography in the characterization of pancreatic mucinous cystadenoma. J Ultrasound Med 23(8):1125–1129PubMed

D’Onofrio M, Malago R, Vecchiato F, Zamboni G, Testoni M, Falconi M et al (2005a) Contrast-enhanced ultrasonography of small solid pseudopapillary tumors of the pancreas: enhancement pattern and pathologic correlation of 2 cases. J Ultrasound Med 24(6):849–854PubMed

D’Onofrio M, Malago R, Zamboni G, Vasori S, Falconi M, Capelli P et al (2005b) Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 5(4–5):398–402PubMedCrossRef

D’Onofrio M, Zamboni G, Tognolini A, Malago R, Faccioli N, Frulloni L et al (2006) Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 12(26):4181–4184PubMed

Dietrich CF, Lee JH, Herrmann G, Teuber G, Roth WK, Caspary WF et al (1997) Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 26(2):467–472PubMedCrossRef

Dietrich CF, Leuschner MS, Zeuzem S, Herrmann G, Sarrazin C, Caspary WF et al (1999) Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the disease. Eur J Gastroenterol Hepatol 11(7):747–753PubMedCrossRef

Dietrich CF, Chichakli M, Hirche TO, Bargon J, Leitzmann P, Wagner TO et al (2002) Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosis. J Ultrasound Med 21(4):409–416PubMed

Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G (2004) Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 53(3):401–405PubMedCrossRef

Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A et al (2006) Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 12(11):1699–1705PubMed

Goldstein HM, Neiman HL, Bookstein JJ (1974) Angiographic evaluation of pancreatic disease. A further appraisal. Radiology 112(2):275–282PubMed

Hirooka Y, Goto H, Ito A, Hayakawa S, Watanabe Y, Ishiguro Y et al (1998) Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 93(4):632–635PubMedCrossRef

Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF (2006) Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 12(2):246–250PubMed

Itoh T, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K et al (2005) Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 100(1):144–152PubMedCrossRef

Johnson PT, Outwater EK (1999) Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology 212(1):213–218PubMed

Kitano M (2005) Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas. J Gastroenterol 40(6):666–668PubMedCrossRef

Kitano M, Kudo M, Maekawa K, Suetomi Y, Sakamoto H, Fukuta N et al (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53(6):854–859PubMedCrossRef

Kobayashi A, Yamaguchi T, Ishihara T, Tadenuma H, Nakamura K, Saisho H (2005) Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut 54(7):1047PubMedCrossRef

Koito K, Namieno T, Nagakawa T, Morita K (1997) Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles. AJR Am J Roentgenol 169(5):1263–1267PubMed

Koito K, Namieno T, Nagakawa T, Hirokawa N, Ichimura T, Syonai T et al (2001) Pancreas: imaging diagnosis with color/power Doppler ultrasonography, endoscopic ultrasonography, and intraductal ultrasonography. Eur J Radiol 38(2):94–104PubMedCrossRef

Masaki T, Ohkawa S, Amano A, Ueno M, Miyakawa K, Tarao K (2005) Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 103(5):1026–1035PubMedCrossRef

Miyata T, Tomiyama T, Tano S, Ueno N (1998) Differential diagnosis of pancreatic tumor by contrast enhanced color Doppler ultrasonography. Nippon Rinsho 56(4):1024–1029PubMed

Nagase M, Furuse J, Ishii H, Yoshino M (2003) Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 22(8):789–795PubMed

Numata K, Ozawa Y, Kobayashi N, Kubota T, Shimada H, Nozawa A et al (2005) Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol 40(6):631–640PubMedCrossRef

Ohshima T, Yamaguchi T, Ishihara T, Yoshikawa M, Kobayashi A, Sakaue N et al (2004) Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 28(3):335–343PubMedCrossRef

Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B et al (2005) Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 26(4):277–284PubMedCrossRef

Oshikawa O, Tanaka S, Ioka T, Nakaizumi A, Hamada Y, Mitani T (2002) Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J Roentgenol 178(5):1133–1137PubMed

Rickes S, Unkrodt K, Ocran K, Neye H, Wermke W (2003) Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy. Pancreas 26(1):76–81PubMedCrossRef

Rickes S, Randhan W, Malfertheiner P (2004) Differentiation of cystic pancreatic lesions by echo-enhanced sonography with pulse inversion imaging—presentation of case reports. Z Gastroenterol 42(4):317–321PubMedCrossRef

Rickes S, Monkemuller K, Malfertheiner P (2006) Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. JOP 7(6):584–592PubMed

Schima W (2006) MRI of the pancreas: tumours and tumour-simulating processes. Cancer Imaging 6:199–203PubMedCrossRef

Schueller G, Schima W, Schueller-Weidekamm C, Weber M, Stift A, Gnant M et al (2006) Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast. Radiology 241(2):441–448PubMedCrossRef

Sofuni A, Iijima H, Moriyasu F, Nakayama D, Shimizu M, Nakamura K et al (2005) Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 40(5):518–525PubMedCrossRef

von Herbay A, Vogt C, Haussinger D (2002) Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 179(5):1273–1279

von Herbay A, Vogt C, Willers R, Haussinger D (2004) Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 23(12):1557–1568

Yang EY, Joehl RJ, Talamonti MS (1994) Cystic neoplasms of the pancreas. J Am Coll Surg 179(6):747–757PubMed

Titel: Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound
verfasst von: C. F. Dietrich
B. Braden
M. Hocke
M. Ott
A. Ignee
Publikationsdatum: 01.06.2008
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2008
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-007-0326-6

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound

Abstract

Background

Patients and methods

Results

Conclusion

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Patients and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2008

Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit

Synergistic antitumor effect of CXCL10 with hyperthermia

Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine

Kaposi’s sarcoma after liver transplantation

A logistic regression model for predicting malignant pheochromocytomas

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie